Literature DB >> 31018978

Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses.

Luciano Cascione1,2, Andrea Rinaldi1, Alessio Bruscaggin1, Chiara Tarantelli1, Alberto J Arribas1,2, Ivo Kwee1,2,3, Lorenza Pecciarini4, Afua A Mensah1, Valeria Spina1, Elaine Y L Chung1, Lodovico Terzi di Bergamo1,2, Stephan Dirnhofer5, Alexandar Tzankov5, Roberto N Miranda6, Ken H Young6, Alexandra Traverse-Glehen7, Gianluca Gaidano8, Steven H Swerdlow9, Randy Gascoyne10, Raul Rabadan11, Maurilio Ponzoni4, Govind Bhagat12, Davide Rossi1,13, Emanuele Zucca13, Francesco Bertoni14.   

Abstract

Entities:  

Year:  2019        PMID: 31018978      PMCID: PMC6959164          DOI: 10.3324/haematol.2018.214957

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications.

Authors:  Wee J Chng; Ellen D Remstein; Rafael Fonseca; P Leif Bergsagel; Julie A Vrana; Paul J Kurtin; Ahmet Dogan
Journal:  Blood       Date:  2008-10-30       Impact factor: 22.113

2.  Marginal zone lymphomas with monocytoid morphology express T-bet and are associated with a low number of T cells in extranodal locations.

Authors:  Philipp Lohneis; Stephan Wienert; Frederick Klauschen; Andrea Ullrich; Ioannis Anagnostopoulos; Korinna Jöhrens
Journal:  Leuk Lymphoma       Date:  2013-06-04

3.  Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.

Authors:  Fazila Asmar; Vasu Punj; Jesper Christensen; Marianne T Pedersen; Anja Pedersen; Anders B Nielsen; Christoffer Hother; Ulrik Ralfkiaer; Peter Brown; Elisabeth Ralfkiaer; Kristian Helin; Kirsten Grønbæk
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

4.  Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.

Authors:  Andrea Rinaldi; Michael Mian; Ekaterina Chigrinova; Luca Arcaini; Govind Bhagat; Urban Novak; Paola M V Rancoita; Cassio P De Campos; Francesco Forconi; Randy D Gascoyne; Fabio Facchetti; Maurilio Ponzoni; Silvia Govi; Andrés J M Ferreri; Manuela Mollejo; Miguel A Piris; Luca Baldini; Jean Soulier; Catherine Thieblemont; Vincenzo Canzonieri; Valter Gattei; Roberto Marasca; Silvia Franceschetti; Gianluca Gaidano; Alessandra Tucci; Silvia Uccella; Maria Grazia Tibiletti; Stephan Dirnhofer; Claudio Tripodo; Claudio Doglioni; Riccardo Dalla Favera; Franco Cavalli; Emanuele Zucca; Ivo Kwee; Francesco Bertoni
Journal:  Blood       Date:  2010-11-29       Impact factor: 22.113

5.  Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity.

Authors:  Anatoly V Rubtsov; Kira Rubtsova; Aryeh Fischer; Richard T Meehan; Joann Z Gillis; John W Kappler; Philippa Marrack
Journal:  Blood       Date:  2011-05-04       Impact factor: 22.113

6.  T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders.

Authors:  David M Dorfman; Eun Sook Hwang; Aliakbar Shahsafaei; Laurie H Glimcher
Journal:  Am J Clin Pathol       Date:  2004-08       Impact factor: 2.493

Review 7.  Chromatin modifying gene mutations in follicular lymphoma.

Authors:  Michael R Green
Journal:  Blood       Date:  2017-11-20       Impact factor: 22.113

Review 8.  Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics.

Authors:  Brunangelo Falini; Paolo Sportoletti; Lorenzo Brunetti; Maria Paola Martelli
Journal:  Br J Haematol       Date:  2015-04-19       Impact factor: 8.615

9.  The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.

Authors:  Hyunchul Jung; Hae Yong Yoo; Seung Ho Lee; Sohyun Shin; Sang Cheol Kim; Sejoon Lee; Je-Gun Joung; Jae-Yong Nam; Daeun Ryu; Jae Won Yun; Jung Kyoon Choi; Ambarnil Ghosh; Kyeong Kyu Kim; Seok Jin Kim; Won Seog Kim; Woong-Yang Park; Young Hyeh Ko
Journal:  Oncotarget       Date:  2017-03-07

10.  Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.

Authors:  Patricia Johansson; Ludger Klein-Hitpass; Florian Grabellus; Georg Arnold; Wolfram Klapper; Roman Pförtner; Ulrich Dührsen; Anja Eckstein; Jan Dürig; Ralf Küppers
Journal:  Oncotarget       Date:  2016-09-20
View more
  17 in total

1.  Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734.

Authors:  Filippo Spriano; Eugenio Gaudio; Luciano Cascione; Chiara Tarantelli; Federica Melle; Giovanna Motta; Valdemar Priebe; Andrea Rinaldi; Gaetanina Golino; Afua Adjeiwaa Mensah; Luca Aresu; Emanuele Zucca; Stefano Pileri; Michael Witcher; Bill Brown; Claes Wahlestedt; Francis Giles; Anastasios Stathis; Francesco Bertoni
Journal:  Blood Adv       Date:  2020-09-08

2.  A roadmap for clinical trial design in marginal zone lymphoma.

Authors:  Juan Pablo Alderuccio; Thomas Habermann; Russ Kuker; Craig H Moskowitz; Andrew D Zelenetz; Izidore S Lossos
Journal:  Am J Hematol       Date:  2022-09-12       Impact factor: 13.265

3.  The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.

Authors:  Marco Magistri; Lanie E Happ; Jeremy Ramdial; XiaoQing Lu; Vasileios Stathias; Kranthi Kunkalla; Nitin Agarwal; Xiaoyu Jiang; Stephan C Schürer; Sander R Dubovy; Jennifer R Chapman; Francisco Vega; Sandeep Dave; Izidore S Lossos
Journal:  Cancer Res Commun       Date:  2021-10-13

4.  Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome.

Authors:  Johanna A A Bult; Jessica R Plaça; Erlin A Haacke; M Martijn Terpstra; Gwenny M Verstappen; Frederik K L Spijkervet; Frans G M Kroese; Wouter J Plattel; Joost S P Vermaat; Hendrika Bootsma; Bert van der Vegt; Arjan Diepstra; Anke van den Berg; Klaas Kok; Marcel Nijland
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

5.  Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models.

Authors:  Chiara Tarantelli; Martin Lange; Eugenio Gaudio; Luciano Cascione; Filippo Spriano; Ivo Kwee; Alberto J Arribas; Andrea Rinaldi; Thibaud Jourdan; Melanie Berthold; Andrea Sturz; Carolyn Sperl; Francesco Margheriti; Lorenzo Scalise; Giuseppe Gritti; Davide Rossi; Anastasios Stathis; Ningshu Liu; Emanuele Zucca; Oliver Politz; Francesco Bertoni
Journal:  Blood Adv       Date:  2020-03-10

6.  Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.

Authors:  Bryan Rea; Yen-Chun Liu; Alanna Maguire; Lorinda A Soma; Chris M Bacon; Michael G Bayerl; Molly H Smith; Michael T Barrett; Steven H Swerdlow; Sarah E Gibson
Journal:  Mod Pathol       Date:  2021-12-24       Impact factor: 8.209

7.  Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing.

Authors:  Patricia Johansson; Ludger Klein-Hitpass; Bettina Budeus; Matthias Kuhn; Chris Lauber; Michael Seifert; Ingo Roeder; Roman Pförtner; Martin Stuschke; Ulrich Dührsen; Anja Eckstein; Jan Dürig; Ralf Küppers
Journal:  Cancers (Basel)       Date:  2020-04-17       Impact factor: 6.639

Review 8.  Primary Pulmonary B-Cell Lymphoma: A Review and Update.

Authors:  Francesca Sanguedolce; Magda Zanelli; Maurizio Zizzo; Alessandra Bisagni; Alessandra Soriano; Giorgia Cocco; Andrea Palicelli; Giacomo Santandrea; Cecilia Caprera; Matteo Corsi; Giulia Cerrone; Raffaele Sciaccotta; Giovanni Martino; Linda Ricci; Francesco Sollitto; Domenico Loizzi; Stefano Ascani
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

Review 9.  Recent Advances in the Genetic of MALT Lymphomas.

Authors:  Juan José Rodríguez-Sevilla; Antonio Salar
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

Review 10.  KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.

Authors:  Elena Vendramini; Riccardo Bomben; Federico Pozzo; Tamara Bittolo; Erika Tissino; Valter Gattei; Antonella Zucchetto
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.